Moore SE - Search Results

1

Induction of anti-tumor immunity by intrasplenic administration of a carcinoembryonic antigen DNA vaccine.

White SA, LoBuglio AF, Arani RB, Pike MJ, Moore SE, Barlow DL, Conry RM. White SA, et al. Among authors: moore se. J Gene Med. 2000 Mar-Apr;2(2):135-40. doi: 10.1002/(SICI)1521-2254(200003/04)2:2<135::AID-JGM88>3.0.CO;2-O. J Gene Med. 2000. PMID: 10809147

2

Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients.

Conry RM, Curiel DT, Strong TV, Moore SE, Allen KO, Barlow DL, Shaw DR, LoBuglio AF. Conry RM, et al. Among authors: moore se. Clin Cancer Res. 2002 Sep;8(9):2782-7. Clin Cancer Res. 2002. PMID: 12231517 Clinical Trial.

3

A carcinoembryonic antigen polynucleotide vaccine for human clinical use.

Conry RM, LoBuglio AF, Loechel F, Moore SE, Sumerel LA, Barlow DL, Pike J, Curiel DT. Conry RM, et al. Among authors: moore se. Cancer Gene Ther. 1995 Mar;2(1):33-8. Cancer Gene Ther. 1995. PMID: 7621253 Clinical Trial.

4

A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity.

Conry RM, LoBuglio AF, Loechel F, Moore SE, Sumerel LA, Barlow DL, Curiel DT. Conry RM, et al. Among authors: moore se. Gene Ther. 1995 Jan;2(1):59-65. Gene Ther. 1995. PMID: 7712333

5

Immune response to a carcinoembryonic antigen polynucleotide vaccine.

Conry RM, LoBuglio AF, Kantor J, Schlom J, Loechel F, Moore SE, Sumerel LA, Barlow DL, Abrams S, Curiel DT. Conry RM, et al. Among authors: moore se. Cancer Res. 1994 Mar 1;54(5):1164-8. Cancer Res. 1994. PMID: 8118800

6

Selected strategies to augment polynucleotide immunization.

Conry RM, Widera G, LoBuglio AF, Fuller JT, Moore SE, Barlow DL, Turner J, Yang NS, Curiel DT. Conry RM, et al. Among authors: moore se. Gene Ther. 1996 Jan;3(1):67-74. Gene Ther. 1996. PMID: 8929913

7

Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen.

Conry RM, White SA, Fultz PN, Khazaeli MB, Strong TV, Allen KO, Barlow DL, Moore SE, Coan PN, Davis I, Curiel DT, LoBuglio AF. Conry RM, et al. Among authors: moore se. Clin Cancer Res. 1998 Nov;4(11):2903-12. Clin Cancer Res. 1998. PMID: 9829759

8

Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration.

Conry RM, Khazaeli MB, Saleh MN, Allen KO, Barlow DL, Moore SE, Craig D, Arani RB, Schlom J, LoBuglio AF. Conry RM, et al. Among authors: moore se. Clin Cancer Res. 1999 Sep;5(9):2330-7. Clin Cancer Res. 1999. PMID: 10499601 Clinical Trial.

9

Human autoantibodies to carcinoembryonic antigen (CEA) induced by a vaccinia-CEA vaccine.

Conry RM, Allen KO, Lee S, Moore SE, Shaw DR, LoBuglio AF. Conry RM, et al. Among authors: moore se. Clin Cancer Res. 2000 Jan;6(1):34-41. Clin Cancer Res. 2000. PMID: 10656429 Clinical Trial.

10

Development of a polynucleotide vaccine from melanoma antigen recognized by T cells-1 and recombinant protein from melanoma antigen recognized by T cells-1 for melanoma vaccine clinical trials.

Lee SW, Li H, Strong TV, Moore SE, Conry RM. Lee SW, et al. Among authors: moore se. J Immunother. 2000 May-Jun;23(3):379-86. doi: 10.1097/00002371-200005000-00011. J Immunother. 2000. PMID: 10838667

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters